Feature | October 02, 2017

Most Popular Cardiac Technology Content in September 2017 on DAIC

Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.

The biggest cardiac technology story in September was Abbott pulled the Absorb Bioresorbable scaffold stent off the market because poor sales.

October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of September, based on website analytics of the month’s 126,393 pageviews:

Top Cardiology Technology Articles

1. Abbott Will End Sales of Absorb Bioresorbable Stent

2. The Future of Cardiology: 17 Technologies to Watch

3. Oxygen Therapy Does Not Improve Survival in Heart Attack Patients

4. Israeli Hospital Completes First Implant of CORolla Heart Failure Device

5. CT Calcium Scoring for Heart Disease May Lead to Prevention, Treatments

6. Biotronik's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial

7. Abbott, St. Jude Medical Fixes Cybersecurity Vulnerabilities of its Pacemakers, ICDs

8. Intracardiac Echo Should be More Widely Adopted to Minimize Radiation in Catheter Ablations

9. Philips to Develop FFR-Angiography in Partnership With HeartFlow

10. World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy

11. Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System

12. Late-breaking Trial Presentations at ESC 2017

13. Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR

14. VIVA 2017 Late-breaking Clinical Trial Presentations

15. CASTLE-AF Study Results Indicate Catheter Ablation of Atrial Fibrillation as First-Line Treatment for Heart Failure Patients

 

Top 5 Cardiology Videos:

1. VIDEO: Future of Strain Imaging

2. VIDEO: CRT Optimization Using Echo

3. VIDEO: What is Myocardial Strain Imaging?

4. VIDEO: Transcatheter Tricuspid Valve Repair and Replacement Technologies

5. VIDEO: Mitral and Tricuspid Valve Repair Technologies

 

 

Related Most Popular Cardiology Technology Content Links:

Most Popular Cardiac Technology Content in August 2017 on DAIC

Most Popular Cardiac Technology Content in July 2017 on DAIC

Most Popular DAIC Content in June 2017

Most Popular DAIC Content in May 2017

Most Popular Cardiology Articles of 2016 From DAIC

Related Content

Elixir Medical Corporation Unveils Transformational DynamX Stent Featuring Adaptive Segments that Uncage the Stented Artery
News | Stents | January 25, 2018
January 25, 2018 – Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling techno
The TIDES-ACS results show us that the Optimax stent is noninferior in patients with acute coronary syndrome compared to Synergy.

The presentation of the ESC late-breaker TIDES-ACS results show us that the Optimax stent is noninferior in patients with acute coronary syndrome compared to Synergy.

News | Stents | November 24, 2017
November 24, 2017 – During a late-breaking session at the European Society of Cardiology (ESC) 2017 meeting, presente
News | Stents | November 10, 2017
Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portfolio, which now...
OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

Feature | Stents | November 08, 2017
November 8, 2017 – New results from the HARMONEE Japan/U.S.
FDA Approves COBRA REDUCE Trial of 14-Day DAPT With CeloNova Stent
News | Stents | October 27, 2017
CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of CeloNova's...
CeloNova Cobra Pzf stent
Technology | Stents | March 02, 2017
March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc.
OCT, intravascular imaging, stent, good stent apposition on vessel wall, TRANSFORM-OCT study

An OCT image showing good stent strut apposition against the vessel wall.

News | Stents | January 13, 2017
January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD

Gregg W. Stone, M.D., presenting the EXCEL data at TCT 2016 during a standing room only late-breaking trial session.

Feature | Stents | January 12, 2017 | Dave Fornell
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results
Biotronik's Osiro stent, prison IV trial

Biotronik's Osiro ultra-thin strut, sirolimus-eluting stent.

News | Stents | November 09, 2016
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin
OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents | November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
Overlay Init